| Fiscal Year End | Company Status | Exempt Flag |
| December 31 | Delist | N |
|
|
|
|
|
| Incorporation Locations |
| Inc. Date | Expiry Date | Country | Region | Description |
| 4/Jan/1996 | 13/Jul/2014 | Canada | | |
|
|
| Exchange Filing Office |
| Location |
| (not available) |
|
|  |
| Business Type(s) |
| Primary/Secondary | Business Type | Details |
| Primary
| *Holding Company
| (not available)
|
|
| *Research and Development in the Physical, Engineering and Life Sciences
| (not available)
|
|
| *Management, Scientific And Technical Consulting Services
| (not available)
|
| Secondary
| *Research and Development in the Physical, Engineering and Life Sciences
| (not available)
|
|
|
| Securities |
| Symbol | Security Name | Market | Status |
| *WNX.H | *Warnex Inc. | TSX Venture | DELIST |
| *WNX | *Warnex Inc. old | TSX Venture | DELIST |
| *WNX | *Warnex Inc. | TSX Venture | DELIST |
| | *Warnex Pharma Inc. | TSX Venture | DELIST |
| *WNX | *Warnex Pharma Inc. | ASE | DELIST |
|
|
| Name History | From | To |
| *Warnex Inc. | 13/Jan/2012 | 13/Jul/2014 |
| *Warnex Inc. | 24/Jul/2001 | 31/Jan/2003 |
| *Warnex Pharma Inc. | 29/Apr/1996 | 23/Jul/2001 |
|
|
| Company Facts Reconciliation |
| Subject | Date Returned |
| Summer 2013 CFR | Not Received |
|
|
|
|
|
